Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
6.23
+0.77 (14.10%)
Nov 5, 2024, 4:00 PM EST - Market closed

Orchestra BioMed Holdings Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-55.58-49.12-33.61-23.01-21.36
Depreciation & Amortization
0.290.290.220.180.14
Other Amortization
0.040.110.160.22-
Loss (Gain) From Sale of Investments
-2.55-3.8-1.630.292.93
Stock-Based Compensation
9.787.633.410.30.22
Other Operating Activities
1.712.082.6-0.030.07
Change in Accounts Receivable
0.09-00.030.05-0.08
Change in Inventory
0.110.13-0.210-0.03
Change in Accounts Payable
3.610.153.351.08-2.61
Change in Unearned Revenue
-1.48-2.11-2.861.48-5.17
Change in Other Net Operating Assets
-0.59-1.47-0.760.03-0.31
Operating Cash Flow
-44.58-46.13-29.29-19.43-26.18
Capital Expenditures
-0.13-0.08-0.59-0.27-0.54
Investment in Securities
62.5110.77-63.5313.527.69
Other Investing Activities
----0.21-0.19
Investing Cash Flow
62.3810.69-64.1213.0226.97
Long-Term Debt Issued
--10-10
Long-Term Debt Repaid
--10.85-6.45-4-
Net Debt Issued (Repaid)
-10.85-10.853.55-410
Issuance of Common Stock
0.350.250.20.01-
Other Financing Activities
-56.81-10.33--
Financing Cash Flow
-10.546.22103.26-3.9910
Net Cash Flow
7.310.789.85-10.4110.78
Free Cash Flow
-44.71-46.21-29.88-19.7-26.72
Free Cash Flow Margin
-2150.41%-1674.09%-845.74%--468.56%
Free Cash Flow Per Share
-1.26-1.39-1.99-9.33-13.27
Cash Interest Paid
0.41.121.370.39-
Levered Free Cash Flow
-22.91-32.17-10.06-13.86-
Unlevered Free Cash Flow
-22.95-32.28-10.22-13.5-
Change in Net Working Capital
-3.547.92-7.150.08-
Source: S&P Capital IQ. Standard template. Financial Sources.